202 related articles for article (PubMed ID: 35297492)
21. Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines.
Hur JW; Choe JY; Kim DW; Kim HA; Kim SH; Kim WU; Kim YS; Lee HS; Lee SH; Park SH; Park W; Park YB; Suh CH; Shim SC; Song YW; Yoon BY; Yu DY; Yoo DH
Rheumatol Int; 2015 Nov; 35(11):1817-23. PubMed ID: 26342296
[TBL] [Abstract][Full Text] [Related]
22. Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology.
Ho CTK; Mok CC; Cheung TT; Kwok KY; Yip RML;
Clin Rheumatol; 2019 Dec; 38(12):3331-3350. PubMed ID: 31485846
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Ito H; Murata K; Sobue Y; Kojima T; Nishida K; Matsushita I; Kawahito Y; Kojima M; Hirata S; Kaneko Y; Kishimoto M; Kohno M; Mori M; Morinobu A; Murashima A; Seto Y; Sugihara T; Tanaka E; Nakayama T; Harigai M
Mod Rheumatol; 2022 Feb; 32(2):296-306. PubMed ID: 33855932
[TBL] [Abstract][Full Text] [Related]
24. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816
[TBL] [Abstract][Full Text] [Related]
25. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
[TBL] [Abstract][Full Text] [Related]
26. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Fraenkel L; Bathon JM; England BR; St Clair EW; Arayssi T; Carandang K; Deane KD; Genovese M; Huston KK; Kerr G; Kremer J; Nakamura MC; Russell LA; Singh JA; Smith BJ; Sparks JA; Venkatachalam S; Weinblatt ME; Al-Gibbawi M; Baker JF; Barbour KE; Barton JL; Cappelli L; Chamseddine F; George M; Johnson SR; Kahale L; Karam BS; Khamis AM; Navarro-Millán I; Mirza R; Schwab P; Singh N; Turgunbaev M; Turner AS; Yaacoub S; Akl EA
Arthritis Rheumatol; 2021 Jul; 73(7):1108-1123. PubMed ID: 34101376
[TBL] [Abstract][Full Text] [Related]
27. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
[TBL] [Abstract][Full Text] [Related]
28. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
Koike R; Takeuchi T; Eguchi K; Miyasaka N;
Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
[TBL] [Abstract][Full Text] [Related]
29. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
[TBL] [Abstract][Full Text] [Related]
30. Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 update.
Fernandes BM; Guimarães F; Almeida DE; Neto A; Tavares-Costa J; Ribeiro AR; Quintal A; Pereira JP; Silva L; Nóvoa TSD; Faustino A; Vaz C; Khmelinskii N; Samões B; Dourado E; Silva JL; Barcelos A; Mariz E; Guerra M; Santos MJ; Silvério-António M; Teixeira RL; Romão VC; Santos H; Santos-Faria D; Azevedo S; Rodrigues A; Dias JM; Lopes C; Pinto P; Couto M; Miranda LC; Bernardo A; Cruz M; Teixeira F; Mourão AF; Neto A; Teixeira V; Cordeiro A; Barreira S; Inês LS; Capela S; Sepriano A; Canhão H; Fonseca JE; Duarte C; Bernardes M
ARP Rheumatol; 2022; 1(1):63-82. PubMed ID: 35633578
[TBL] [Abstract][Full Text] [Related]
31. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Singh JA; Saag KG; Bridges SL; Akl EA; Bannuru RR; Sullivan MC; Vaysbrot E; McNaughton C; Osani M; Shmerling RH; Curtis JR; Furst DE; Parks D; Kavanaugh A; O'Dell J; King C; Leong A; Matteson EL; Schousboe JT; Drevlow B; Ginsberg S; Grober J; St Clair EW; Tindall E; Miller AS; McAlindon T
Arthritis Rheumatol; 2016 Jan; 68(1):1-26. PubMed ID: 26545940
[TBL] [Abstract][Full Text] [Related]
32. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Fraenkel L; Bathon JM; England BR; St Clair EW; Arayssi T; Carandang K; Deane KD; Genovese M; Huston KK; Kerr G; Kremer J; Nakamura MC; Russell LA; Singh JA; Smith BJ; Sparks JA; Venkatachalam S; Weinblatt ME; Al-Gibbawi M; Baker JF; Barbour KE; Barton JL; Cappelli L; Chamseddine F; George M; Johnson SR; Kahale L; Karam BS; Khamis AM; Navarro-Millán I; Mirza R; Schwab P; Singh N; Turgunbaev M; Turner AS; Yaacoub S; Akl EA
Arthritis Care Res (Hoboken); 2021 Jul; 73(7):924-939. PubMed ID: 34101387
[TBL] [Abstract][Full Text] [Related]
33. Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis.
Kameda H; Fujii T; Nakajima A; Koike R; Sagawa A; Kanbe K; Tomita T; Harigai M; Suzuki Y;
Mod Rheumatol; 2019 Jan; 29(1):31-40. PubMed ID: 29718746
[TBL] [Abstract][Full Text] [Related]
34. [Guidelines for the management of rheumatoid arthritis].
Kawahito Y
Nihon Rinsho; 2016 Jun; 74(6):939-43. PubMed ID: 27311182
[TBL] [Abstract][Full Text] [Related]
35. Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.
Kondo M; Yamada H
Mod Rheumatol; 2019 Nov; 29(6):928-935. PubMed ID: 30334661
[No Abstract] [Full Text] [Related]
36. When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
Fraenkel L; Miller AS; Clayton K; Crow-Hercher R; Hazel S; Johnson B; Rott L; White W; Wiedmeyer C; Montori VM; Singh JA; Nowell WB
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):26-35. PubMed ID: 26545701
[TBL] [Abstract][Full Text] [Related]
37. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
Albrecht K; Krüger K; Wollenhaupt J; Alten R; Backhaus M; Baerwald C; Bolten W; Braun J; Burkhardt H; Burmester GR; Gaubitz M; Gause A; Gromnica-Ihle E; Kellner H; Kuipers J; Krause A; Lorenz HM; Manger B; Nüßlein H; Pott HG; Rubbert-Roth A; Schneider M; Specker C; Schulze-Koops H; Tony HP; Wassenberg S; Müller-Ladner U;
Rheumatol Int; 2014 Jan; 34(1):1-9. PubMed ID: 23942828
[TBL] [Abstract][Full Text] [Related]
38. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
[TBL] [Abstract][Full Text] [Related]
39. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
[TBL] [Abstract][Full Text] [Related]
40. Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.
da Mota LM; Cruz BA; de Albuquerque CP; Gonçalves DP; Laurindo IM; Pereira IA; de Carvalho JF; Pinheiro Gda R; Bertolo MB; Pinto MR; Louzada-Junior P; Xavier RM; Giorgi RD; Lima RA
Rev Bras Reumatol; 2015; 55(6):512-21. PubMed ID: 26456224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
